LONDON: MGC Pharmaceuticals, a European based and Australian listed bio-pharma company, is in the final stages of listing the Company’s shares on the Standard Segment of the Main Market of the London Stock Exchange. As part of the listing process, the Company intends to raise gross proceeds of approximately £5m via institutional and other sophisticated…